| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.10▲ | 4.06▲ | 4.06▲ | 4.04▲ | 4.10▲ |
| MA10 | 4.09▲ | 4.05▲ | 4.07▲ | 3.99▲ | 4.07▲ |
| MA20 | 4.07▲ | 4.05▲ | 4.04▲ | 4.04▲ | 4.58▼ |
| MA50 | 4.05▲ | 4.04▲ | 4.00▲ | 4.09▲ | 5.06▼ |
| MA100 | 4.05▲ | 3.98▲ | 4.01▲ | 4.62▼ | 4.31▼ |
| MA200 | 4.04▲ | 4.01▲ | 4.05▲ | 5.25▼ | 3.49▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.003▲ | 0.004▲ | 0.020▲ | -0.058▼ |
| RSI | 71.295▲ | 62.390▲ | 60.264▲ | 52.506▲ | 42.144▼ |
| STOCH | 96.047▲ | 43.606 | 41.283 | 66.123 | 34.276 |
| WILL %R | -5.263▲ | -31.250 | -26.316 | -13.610▲ | -75.604▼ |
| CCI | 121.368▲ | 82.686 | 122.340▲ | 102.928▲ | -51.001 |
|
Monday, May 18, 2026 01:00 AM
Event will provide an overview of Lymphatic Malformations, the treatment landscape and the TARA-002 clinical program NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA ...
|
|
Tuesday, February 24, 2026 07:23 AM
Protara Therapeutics (NASDAQ:TARA) on February 23, 2026, announced updated interim data from its ongoing Phase 2 ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle ...
|
|
Monday, February 23, 2026 02:05 PM
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 4.13 | 4.175 | 4.005 | 4.12 | 336,940 |
| 06/08/26 | 4.00 | 4.11 | 3.975 | 4.10 | 329,319 |
| 05/08/26 | 4.03 | 4.125 | 3.97 | 4.00 | 478,397 |
| 04/08/26 | 3.98 | 4.095 | 3.97 | 4.01 | 421,517 |
| 03/08/26 | 3.94 | 3.99 | 3.87 | 3.97 | 240,231 |
| 31/07/26 | 4.00 | 4.03 | 3.805 | 3.92 | 292,960 |
| 30/07/26 | 3.80 | 4.045 | 3.7709 | 4.03 | 268,113 |
| 29/07/26 | 3.90 | 3.94 | 3.78 | 3.81 | 649,553 |
| 28/07/26 | 4.06 | 4.06 | 3.86 | 3.94 | 371,444 |
| 27/07/26 | 4.07 | 4.14 | 3.995 | 4.04 | 533,550 |
|
|
||||
|
|
||||
|
|